celecoxib has been researched along with Weight Gain in 4 studies
Weight Gain: Increase in BODY WEIGHT over existing weight.
Excerpt | Relevance | Reference |
---|---|---|
"Previous studies reported promising efficacy for celecoxib in the treatment of cancer cachexia." | 9.27 | Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers. ( Ala, S; Alipour, A; Borhani, S; Janbabai, G; Kouchaki, B; Salehifar, E, 2018) |
" This study evaluated the effects of celecoxib 200 mg/day and rofecoxib 25 mg/day on blood pressure (BP) and edema in a 6-week, randomized, parallel-group, double-blind study in patients > or =65 years of age with osteoarthritis who were treated with fixed antihypertensive regimens." | 9.10 | Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. ( Bello, AE; Fort, JG; Puma, JA; Whelton, A; White, WB, 2002) |
"Previous studies reported promising efficacy for celecoxib in the treatment of cancer cachexia." | 5.27 | Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers. ( Ala, S; Alipour, A; Borhani, S; Janbabai, G; Kouchaki, B; Salehifar, E, 2018) |
"A combination of celecoxib and selenium was used in a randomized double-blind Phase II trial as a preliminary study to a multicenter Phase III colorectal cancer chemoprevention trial using these two agents together." | 5.11 | Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial. ( Alberts, DS; Choquette, K; Chow, HH; Fish, A; Francis, J; Frank, DH; Gracie, D; Guillen, JM; Roe, DJ, 2004) |
" This study evaluated the effects of celecoxib 200 mg/day and rofecoxib 25 mg/day on blood pressure (BP) and edema in a 6-week, randomized, parallel-group, double-blind study in patients > or =65 years of age with osteoarthritis who were treated with fixed antihypertensive regimens." | 5.10 | Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. ( Bello, AE; Fort, JG; Puma, JA; Whelton, A; White, WB, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kouchaki, B | 1 |
Janbabai, G | 1 |
Alipour, A | 1 |
Ala, S | 1 |
Borhani, S | 1 |
Salehifar, E | 1 |
Whelton, A | 1 |
White, WB | 1 |
Bello, AE | 1 |
Puma, JA | 1 |
Fort, JG | 1 |
Frank, DH | 1 |
Roe, DJ | 1 |
Chow, HH | 1 |
Guillen, JM | 1 |
Choquette, K | 1 |
Gracie, D | 1 |
Francis, J | 1 |
Fish, A | 1 |
Alberts, DS | 1 |
Cerchietti, LC | 1 |
Navigante, AH | 1 |
Castro, MA | 1 |
4 trials available for celecoxib and Weight Gain
Article | Year |
---|---|
Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
Topics: Anorexia; Antineoplastic Agents, Hormonal; Cachexia; Celecoxib; Combined Modality Therapy; Double-Bl | 2018 |
Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; | 2002 |
Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial.
Topics: Administration, Oral; Adult; Aged; Anticarcinogenic Agents; Celecoxib; Colorectal Neoplasms; Double- | 2004 |
Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Appetite; C-Reactive Protein; Cachexia; Celecoxib; Cohort Studies; C | 2007 |